Full name
NOVUM-MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1 | 0,6 | 1,2 | 120,7 |
Gross profit (loss) | 1,4 | 1,1 | 1,9 | 76,5 |
EBITDA | 1,5 | 1,2 | 2 | 61 |
Short time liabilities | 0,4 | 0,4 | 0,5 | 30,5 |
Other operating costs | 0 | 0 | 0 | 235 |
Equity capital | 1,2 | 1,1 | 1,9 | 65,9 |
Operating profit (EBIT) | 1,4 | 1,1 | 1,9 | 76,5 |
Assets | 1,6 | 1,5 | 2,6 | 65,9 |
Net profit (loss) | 1,3 | 1 | 1,8 | 75,2 |
Cash | 1 | 0,9 | 1,5 | 67,7 |
Net income from sale | 8,8 | 5 | 7,3 | 44,6 |
Liabilities and provisions for liabilities | 0,4 | 0,4 | 0,7 | 66,1 |
Working assets | 1,6 | 1,5 | 2,3 | 54,2 |
Other income costs | 0,5 | 0,5 | 0,7 | 31,4 |
Depreciation | 0 | 0,1 | 0 | -66,6 |
% | % | % | p.p. | |
Profitability of capital | 107,3 | 87,6 | 92,5 | 4,9 |
Equity capital to total assets | 75,3 | 74,2 | 74,1 | -0,1 |
Gross profit margin | 16,2 | 21,7 | 26,5 | 4,8 |
EBITDA Margin | 16,4 | 24,3 | 27,1 | 2,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 16 | 29 | 26 | -3 |
Current financial liquidity indicator | 4.172220230102539 | 3.721553325653076 | 4.39679479598999 | 0,7 |
Net dept to EBITDA | -0.6409659385681152 | -0.7083321213722229 | -0.7648064494132996 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane